Anne Lynn S. Chang

32.3k total citations · 4 hit papers
220 papers, 12.5k citations indexed

About

Anne Lynn S. Chang is a scholar working on Epidemiology, Dermatology and Molecular Biology. According to data from OpenAlex, Anne Lynn S. Chang has authored 220 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Epidemiology, 64 papers in Dermatology and 60 papers in Molecular Biology. Recurrent topics in Anne Lynn S. Chang's work include Nonmelanoma Skin Cancer Studies (57 papers), Hedgehog Signaling Pathway Studies (44 papers) and Cancer and Skin Lesions (28 papers). Anne Lynn S. Chang is often cited by papers focused on Nonmelanoma Skin Cancer Studies (57 papers), Hedgehog Signaling Pathway Studies (44 papers) and Cancer and Skin Lesions (28 papers). Anne Lynn S. Chang collaborates with scholars based in United States, Canada and Australia. Anne Lynn S. Chang's co-authors include Manolis Savva, Angela Dai, Thomas Funkhouser, Maciej Halber, Matthias Nießner, Anthony E. Oro, Christopher D. Manning, Kavita Y. Sarin, Matthias NieBner and Shalini Mohan and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Anne Lynn S. Chang

208 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ScanNet: Richly-Annotated 3D Reconstructions of Indoor Scenes

2017 2.3k citations Anne Lynn S. Chang, Manolis Savva et al. profile →
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

2012 1.0k citations Aleksandar Sekulić, Michael R. Migden et al. New England Journal of Medicine profile →
Matterport3D: Learning from RGB-D Data in Indoor Environments

2017 950 citations Anne Lynn S. Chang, Manolis Savva et al. profile →
Clonal replacement of tumor-specific T cells following PD-1 blockade

2019 876 citations Kathryn E. Yost, Ansuman T. Satpathy et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Lynn S. Chang United States	48	3.8k	3.4k	2.3k	2.3k	2.3k	220	12.5k
Ping Luo China	60	454 0.1×	15.8k 4.7×	100 0.0×	555 0.2×	142 0.1×	237	21.6k
John A. McDonald United States	43	3.9k 1.0×	1.7k 0.5×	29 0.0×	483 0.2×	572 0.3×	100	11.5k
Martin Werner Germany	58	3.5k 0.9×	640 0.2×	125 0.1×	3.7k 1.6×	681 0.3×	494	14.2k
Craig W. Reynolds United States	36	1.2k 0.3×	2.1k 0.6×	34 0.0×	884 0.4×	876 0.4×	84	13.0k
Min Tan China	59	1.4k 0.4×	2.5k 0.7×	22 0.0×	431 0.2×	216 0.1×	703	14.7k
Dagan Feng Australia	61	548 0.1×	6.8k 2.0×	66 0.0×	979 0.4×	494 0.2×	692	15.2k
Xilin Chen China	68	603 0.2×	15.0k 4.5×	114 0.0×	149 0.1×	254 0.1×	475	19.5k
Lifeng Wang China	37	4.2k 1.1×	555 0.2×	54 0.0×	796 0.3×	993 0.4×	172	10.0k
Andre Esteva United States	13	878 0.2×	1.5k 0.5×	291 0.1×	2.2k 1.0×	991 0.4×	30	11.9k
Susan M. Swetter United States	42	2.3k 0.6×	1.0k 0.3×	1.9k 0.8×	6.7k 2.9×	2.4k 1.1×	141	15.1k

Countries citing papers authored by Anne Lynn S. Chang

Since Specialization

Citations

This map shows the geographic impact of Anne Lynn S. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Lynn S. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Lynn S. Chang more than expected).

Fields of papers citing papers by Anne Lynn S. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Lynn S. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Lynn S. Chang. The network helps show where Anne Lynn S. Chang may publish in the future.

Co-authorship network of co-authors of Anne Lynn S. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Lynn S. Chang. A scholar is included among the top collaborators of Anne Lynn S. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Lynn S. Chang. Anne Lynn S. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peris, Ketty, Alexander Stratigos, Karl D. Lewis, et al.. (2024). Health‐related quality of life in patients with metastatic basal cell carcinoma treated with cemiplimab: Analysis of a phase 2 trial. Cancer Medicine. 13(14). e7360–e7360. 2 indexed citations

Jiang, Hanxiao, et al.. (2022). Articulated 3D Human-Object Interactions From RGB Videos: An Empirical Analysis of Approaches and Challenges. 312–321. 7 indexed citations

Jain, Unnat, et al.. (2021). Language-Aligned Waypoint (LAW) Supervision for Vision-and-Language Navigation in Continuous Environments. Proceedings of the 2021 Conference on Empirical Methods in Natural Language Processing. 4018–4028. 25 indexed citations

Harden, Jamie L., et al.. (2020). Paired Transcriptomic and Proteomic Analysis Implicates IL-1β in the Pathogenesis of Papulopustular Rosacea Explants. Journal of Investigative Dermatology. 141(4). 800–809. 16 indexed citations

Yost, Kathryn E., Ansuman T. Satpathy, Daniel K. Wells, et al.. (2019). Clonal replacement of tumor-specific T cells following PD-1 blockade. Nature Medicine. 25(8). 1251–1259. 876 indexed citations breakdown →

Chang, Julia, et al.. (2017). Association Between Programmed Death Ligand 1 Expression in Patients With Basal Cell Carcinomas and the Number of Treatment Modalities. JAMA Dermatology. 153(4). 285–285. 42 indexed citations

Chang, Anne Lynn S., Karl D. Lewis, Sarah T. Arron, et al.. (2016). Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma. Oncotarget. 7(46). 76118–76124. 17 indexed citations

Lear, John T., Ralf Gutzmer, Michael R. Migden, et al.. (2016). Investigator-assessed efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma: results of the BOLT 30-month analysis. Melanoma Research. 1 indexed citations

Chang, Anne Lynn S., Valentin I. Spitkovsky, Christopher D. Manning, & Eneko Agirre. (2016). A comparison of named-entity disambiguation and word sense disambiguation. Language Resources and Evaluation. 860–867. 11 indexed citations

10.

Atwood, Scott X., Kavita Y. Sarin, Ramon J. Whitson, et al.. (2015). Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma. Cancer Cell. 27(3). 342–353. 313 indexed citations

11.

Danial, Christina, Kavita Y. Sarin, Anthony E. Oro, & Anne Lynn S. Chang. (2015). An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib. Clinical Cancer Research. 22(6). 1325–1329. 126 indexed citations

12.

Mohan, Shalini & Anne Lynn S. Chang. (2014). Precision medicine and precision therapeutics: Hedgehog signaling pathway, basal cell carcinoma and beyond. Seminars in Cutaneous Medicine and Surgery. 33(2). 68–71. 3 indexed citations

13.

Chang, Anne Lynn S., et al.. (2014). Emergence of chemoresistance in a metastatic basal cell carcinoma patient after complete response to hedgehog pathway inhibitor vismodegib (GDC‐0449). Australasian Journal of Dermatology. 55(3). 218–221. 15 indexed citations

14.

Zhu, Gefei Alex, Uma Sundram, & Anne Lynn S. Chang. (2014). Two Different Scenarios of Squamous Cell Carcinoma Within Advanced Basal Cell Carcinomas. JAMA Dermatology. 150(9). 970–970. 41 indexed citations

15.

Danial, Christina, Bharathi Lingala, Raymond R. Balise, et al.. (2013). Markedly improved overall survival in 10 consecutive patients with metastatic basal cell carcinoma. British Journal of Dermatology. 169(3). 673–676. 29 indexed citations

16.

Atwood, Scott X., Anne Lynn S. Chang, & Anthony E. Oro. (2012). Hedgehog pathway inhibition and the race against tumor evolution. The Journal of Cell Biology. 199(2). 193–197. 87 indexed citations

17.

Sekulić, Aleksandar, Michael R. Migden, Anthony E. Oro, et al.. (2012). Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma. New England Journal of Medicine. 366(23). 2171–2179. 1011 indexed citations breakdown →

18.

Chang, Anne Lynn S. & Valentin I. Spitkovsky. (2011). Strong Baselines for Cross-Lingual Entity Linking.. Theory and applications of categories. 3 indexed citations

19.

Surdeanu, Mihai, Sonal Gupta, John Bauer, et al.. (2011). Stanford's Distantly-Supervised Slot-Filling System. Theory and applications of categories. 21 indexed citations

20.

Agirre, Eneko, Anne Lynn S. Chang, Daniel Jurafsky, et al.. (2009). Stanford-UBC at TAC-KBP. Theory and applications of categories. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact